DGAP-Adhoc: UBS to buy back outstanding bonds in public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: UBS to buy back outstanding bonds in public tender offer

UBS AG / Key word(s): Bond 02.12.2013 08:03 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- UBS to buy back outstanding bonds in public tender offer UBS offers to buy back certain outstanding tier 2 and senior bonds for cash up to approximately CHF 2.15 billion. Zurich/Basel, 2 December 2013 - UBS announces today that it is making a cash tender offer in relation to five Swiss franc, euro or pound sterling subordinated bonds and six Swiss franc, euro, Italian lira or pound sterling senior unsecured bonds, for a maximum aggregate principal amount of EUR 1.75 billion, equivalent to approximately CHF 2.15 billion. The offer is subject to increase or decrease and other conditions as set out in the tender offer memorandum. The subordinated bonds subject to this offer count as tier 2 capital under the BIS Basel III phase-in rules currently in effect, but are not eligible as tier 2 capital on a BIS Basel III fully applied basis. This transaction is consistent with our proactive approach to reducing our balance sheet and future interest expense while maintaining our strong liquidity, funding and capital position. We estimate that the transaction will reduce our BIS Basel III phase-in total capital ratio by 0.2% - 0.5%. We expect to incur a small loss on this transaction, which we expect to recover in the short-term through the reduction in future interest expense. The repurchase of the tier 2 bonds will not affect our CET1 ratio, but the expected loss associated with this transaction may have an insignificant effect on it. The tender offer period will end on 13 December 2013, unless extended, re-opened or earlier terminated as provided in the tender offer memorandum. UBS AG Investor contact Switzerland: +41-44-234 41 00 Media contact Switzerland: +41-44-234 85 00 UK: +44-207-567 47 14 Americas: +1-212-882 58 57 APAC: +852-297-1 82 00 www.ubs.com OFFER AND DISTRIBUTION RESTRICTIONS This announcement and the tender offer memorandum produced in connection with the offers described therein (the 'Tender Offer Memorandum' and the 'Offers' respectively) do not constitute an offer or an invitation to participate in the Offers in or from the United States or any other jurisdiction in or from which, or to or from any person to or from whom, it is unlawful to make such offer or invitation or for there to be such participation under applicable laws. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum come are required by each of UBS AG (the 'Offeror'), the dealer managers and Lucid Issuer Services Limited (the 'Tender Agent') to inform themselves about and to observe any such restrictions. United States The Offers are not being made and will not be made, directly or indirectly, in or into, or by use of the mails of, or by any means or instrumentality of interstate or foreign commerce of, or of any facilities of a national securities exchange of, the United States. This includes, but is not limited to, facsimile transmission, electronic mail, telex, telephone and the internet. The securities may not be tendered in any Offer by any such use, means, instrumentality or facility from or within the United States or by persons located or resident in the United States. Accordingly, copies of the Tender Offer Memorandum and any other documents or materials relating to the Offers are not being, and must not be, directly or indirectly, mailed or otherwise transmitted, distributed or forwarded (including, without limitation, by custodians, nominees or trustees) in or into the United States or to any persons located or resident in the United States. Any purported tender of securities in an Offer resulting directly or indirectly from a violation of these restrictions will be invalid and any purported tender of securities made by a person located or resident in the United States, or any agent, fiduciary or other Intermediary acting on a non-discretionary basis for a principal giving instructions from within the United States will be invalid and will not be accepted. Each holder participating in an Offer will be deemed to represent that it is not located or resident in the United States and is not participating in such Offer from the United States or it is acting on a non-discretionary basis for a principal located outside the United States that is not giving an order to participate in such Offer from the United States. For the purposes of this and the above paragraph, 'United States' means the United States of America, its territories and possessions, any state of the United States of America and the District of Columbia. United Kingdom The communication of the Tender Offer Memorandum and any other documents or materials relating to the Offers has not been approved by an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000 (the 'FSMA'). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of such documents and/or materials is exempt from the restriction on financial promotions under section 21(1) of the FSMA on the basis that it is only directed at and may only be communicated to (1) persons falling within the definition of investment professional (as defined in Article 19(5) of the Order), (2) those persons who are existing members or creditors of the Offeror or other persons within Article 43(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and (3) any other persons to whom such documents and/or materials may lawfully be communicated in circumstances in which section 21(1) of the FSMA does not apply to the Offeror. Belgium Neither the Tender Offer Memorandum nor any other documents or materials relating to the Offers have been submitted to or will be submitted for approval or recognition to the Financial Services and Markets Authority (Autorité des services et marchés financiers / Autoriteit voor financiële diensten en markten) and, accordingly, the Offers may not be made in Belgium by way of a public offering, as defined in Articles 3 and 6 of the Belgian Law of 1 April 2007 on public takeover bids as amended or replaced from time to time. Accordingly, the Offers may not be advertised and the Offers will not be extended, and neither the Tender Offer Memorandum nor any other documents or materials relating to the Offers (including any memorandum, information circular, brochure or any similar documents) has been or shall be distributed or made available, directly or indirectly, to any person in Belgium other than 'qualified investors' in the sense of Article 10 of the Belgian Law of 16 June 2006 on the public offer of placement instruments and the admission to trading of placement instruments on regulated markets, acting on their own account. The Tender Offer Memorandum has been issued only for the personal use of the above qualified investors and exclusively for the purpose of the Offers. Accordingly, the information contained in the Tender Offer Memorandum may not be used for any other purpose or disclosed to any other person in Belgium. France The Offers are not being made, directly or indirectly, to the public in France. Neither the Tender Offer Memorandum nor any other documents or offering materials relating to the Offers, has been or shall be distributed to the public in France and only (i) providers of investment services relating to portfolio management for the account of third parties (personnes fournissant le service d'investissement de gestion de portefeuille pour compte de tiers) and/or (ii) qualified investors (investisseurs qualifiés) acting for their own account, other than individuals, all as defined in, and in accordance with, Articles L.411-1, L.411-2 and D.411-1 of the French Code monétaire et financier, are eligible to participate in the Offers. The Tender Offer Memorandum has not been submitted to the clearance procedures (visa) of the Autorité des marchés financiers. Italy None of the Offers, the Tender Offer Memorandum or any other documents or materials relating to the Offers has been or will be submitted to the clearance procedure of the Commissione Nazionale per le Società e la Borsa ('CONSOB'), pursuant to applicable Italian laws and regulations. The Offers are being carried out in the Republic of Italy ('Italy') as an exempted offer pursuant to article 101-bis, paragraph 3-bis of the Legislative Decree No. 58 of 24 February 1998, as amended (the 'Financial Services Act') and article 35-bis, paragraph 4 of CONSOB Regulation No. 11971 of 14 May 1999, as amended (the 'CONSOB Regulation'). The Offers are also being carried out in compliance with article 35-bis, paragraph 7 of the CONSOB Regulation. Holders or beneficial owners of the securities located in Italy can offer the securities through authorised persons (such as investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with the Financial Services Act, CONSOB Regulation No. 16190 of 29 October 2007, as amended from time to time, and Legislative Decree No. 385 of 1 September 1993, as amended) and in compliance with applicable laws and regulations or with requirements imposed by CONSOB or any other Italian authority. Each intermediary must comply with the applicable laws and regulations concerning information duties vis-à-vis its clients in connection with the securities or the Offers. Switzerland Neither the Tender Offer Memorandum nor any other offering or marketing material relating to the securities constitutes a prospectus as such term is understood pursuant to article 652a or article 1156 of the Swiss Federal Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. Accordingly, the investor protection rules otherwise applicable to investors in Switzerland do not apply to the Offers. When in doubt, investors based in Switzerland are recommended to contact their legal, financial or tax adviser with respect to the Offers. General The Offers do not constitute an offer to buy or the solicitation of an offer to sell securities in any circumstances in which such offer or solicitation is unlawful. In those jurisdictions where the securities or other laws require the Offers to be made by a licensed broker or dealer and the dealer managers or, where the context so requires, any of their respective affiliates is such a licensed broker or dealer in that jurisdiction, the Offers shall be deemed to be made on behalf of the Offeror by such dealer manager or affiliate (as the case may be) in such jurisdiction. In addition to the representations referred to above in respect of the United States, each holder participating in an Offer will also be deemed to give certain representations in respect of the other jurisdictions referred to above and generally as set out in 'Procedures for Participating in the Offers' in the Tender Offer Memorandum. Any tender of securities for purchase pursuant to an Offer from a holder that is unable to make these representations may be rejected. Each of the Offeror, the dealer managers and the Tender Agent reserves the right, in their absolute discretion, to investigate, in relation to any tender of securities for purchase pursuant to an Offer, whether any such representation given by a holder is correct and, if such investigation is undertaken and as a result the Offeror determines (for any reason) that such representation is not correct, such tender may be rejected. Cautionary Statement Regarding Forward-Looking Statements This release contains statements that constitute 'forward-looking statements'. While these statements represent UBS's expectation concerning future developments, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from UBS's expectations. In addition, these results could depend on other factors that we have previously indicated could affect our business and financial performance which are contained in our past and future filings and reports, including those filed with the SEC. More detailed information about those factors is set forth in documents furnished by UBS and filings made by UBS with the SEC, including UBS's Annual Report on Form 20-F for the year ended 31 December 2012. UBS is not under any obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise 02.12.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: UBS AG Bahnhofstrasse 45 8001 Zürich Switzerland Phone: +41 44 234 11 11 Fax: E-mail: info@ubs.com Internet: www.ubs.com ISIN: CH0024899483, CH0039913899 WKN: UB0BL6 Listed: Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart; Frankfurt in Open Market ; SIX End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal Energy Gets Boost with GRMS Adoption

Updated Category News Views 0

Geothermal's Big Leap with the GRMS The oil and gas sector didn't explode overnight—it leapt due to a consistent, standardized language that spoke to investors like a charm. Now, the geothermal industry is borrowing a page from this book of success with the Geothermal Resources Management System (GRMS). Finally, a framework not just built on hope and hot air, but...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 0

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
First Student Reduces Collisions by 63% with HALO Tech

Updated Category News Views 13

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Continue Reading
VIVIFY and ELISIUM Plan Hydrogen-Powered City

Updated Category News Views 1

Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 28

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 14

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit

Updated Category News Views 11

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Continue Reading
Roof Inspections: Richmond's Key to Home Longevity

Updated Category News Views 17

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 12

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading

Top 5 Most Recently Viewed Articles

Children’s Place Sees Stock Surge Post Impressive Q2 Results

Updated Category News Views 56

Children’s Place Stock Rises After Strong Q2 Earnings Children’s Place, Inc. (NASDAQ: PLCE) has recently attracted a lot of attention as its stock prices soared following the release of its second-quarter earnings. The positive results came as a welcome surprise just before the market opened, leading to a notable increase in trading volumes. Strong Earnings Exceed...

Continue Reading
Yunji Inc. Confirms Compliance with Nasdaq Standards

Updated Category News Views 61

Yunji Inc. (NASDAQ: YJ) made headlines recently after confirming it had regained compliance with Nasdaq standards, signaling a significant recovery from non-compliance issues that had threatened its standing on the exchange. Compliance Rollercoaster: From Non-Compliance to Recovery Backtracking a bit, Yunji faced a stark reality when it was flagged by Nasdaq under Listing...

Continue Reading
Ladybug Nutratech Drives Revenue Growth with Strategic Plans

Updated Category News Views 43

Ladybug Nutratech Unleashes Revenue Growth Initiatives Ladybug Resource Group, Inc. (OTC PINK: LBRG), now known as Ladybug Nutratech, is swiftly positioning itself as a frontrunner in the health and wellness sector. The company has demonstrated an impressive revenue growth of $6.0 million, which reflects an extraordinary increase of 10,527% compared to the same timeline...

Continue Reading
New Findings Show Duvakitug's Efficacy for Inflammatory Bowel Disease

Updated Category News Views 87

Groundbreaking Results from the Duvakitug Study Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) and Sanofi SA (NASDAQ: SNY) have recently unveiled promising data from their RELIEVE UCCD Phase 2b study involving duvakitug, a new treatment for moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD), two prevalent types of inflammatory bowel disease (IBD)....

Continue Reading
Caliway's Innovative Weight Management Drug CBL-514 Advances Development

Updated Category News Views 126

Caliway's CBL-514 is Primed for Phase 2 Clinical Trial Caliway has recently completed its submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA). This submission is critical as it paves the way for a Phase 2 clinical study focusing on weight management using CBL-514, an innovative drug candidate designed to address...

Continue Reading